Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Nang Kuang Pharmaceutical Co Net Margin %?
Nang Kuang Pharmaceutical CoTPE:1752 -1.10%88 Net Margin % is 14.27% as of Dec. 2025, which is 28% above its 10-year median of 11.18. GuruFocus rates TPE:1752 with a GF Score™ of 88/100 and a GF Value™ of NT$46.62 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 818 Medical Devices & Instruments companies, Nang Kuang Pharmaceutical Co ranks better than 76.41% on this metric.
The historical rank and industry rank for Nang Kuang Pharmaceutical Co's Net Margin % or its related term are showing as below:
TPE:1752'
s Net Margin % Range Over the Past 10 Years
Min: 6.58 Med: 11.18 Max: 18.14
Current: 11.3
TPE:1752's Net Margin % is ranked better than 76.41% of 818
companies
in the Medical Devices & Instruments industry
Industry Median: 2.045
vs TPE:1752: 11.30
Nang Kuang Pharmaceutical Co (TPE:1752) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Nang Kuang Pharmaceutical Co Net Margin % Related Terms
Nang Kuang Pharmaceutical Co Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:1752 vs ISRG, BDX, MDLN: Net Margin % Comparison
For the Medical Instruments & Supplies subindustry, Nang Kuang Pharmaceutical Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nang Kuang Pharmaceutical Co Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nang Kuang Pharmaceutical Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Nang Kuang Pharmaceutical Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nang Kuang Pharmaceutical Co (TPE:1752) has a Net Margin % of 14.27% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Nang Kuang Pharmaceutical Co and its competitors. This is 28% above median its historical median of 11.18. Over the past decade, Nang Kuang Pharmaceutical Co's Net Margin % has ranged from 6.58 to 18.14. According to the industry distribution chart, Nang Kuang Pharmaceutical Co ranks #193 out of 818 companies in the Medical Devices & Instruments industry, placing it in the top 23.6%.
Is Nang Kuang Pharmaceutical Co's Net Margin % too high?
Nang Kuang Pharmaceutical Co's current Net Margin % of 14.27% is 28% above median its 10-year median of 11.18. Over the past 10 years, this metric has ranged from a low of 6.58 to a high of 18.14. The Medical Devices & Instruments industry median Net Margin % is 2.05. Nang Kuang Pharmaceutical Co's value of 14.27% is 597.8% above this industry median. Based on the distribution chart, Nang Kuang Pharmaceutical Co ranks #193 out of 818 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Nang Kuang Pharmaceutical Co has a GF Score™ of 88/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nang Kuang Pharmaceutical Co's Net Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Nang Kuang Pharmaceutical Co ranks #193 out of 818 companies for Net Margin %. This places Nang Kuang Pharmaceutical Co in the top 24% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.05. Nang Kuang Pharmaceutical Co's value of 14.27% is 597.8% above this benchmark. Historically, Nang Kuang Pharmaceutical Co's own Net Margin % has ranged from 6.58 to 18.14 over the past decade. While the company's 10-year median is 11.18 vs. the industry median of 2.05, Nang Kuang Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.05, based on 818 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nang Kuang Pharmaceutical Co's current Net Margin % of 14.27% is 597.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Nang Kuang Pharmaceutical Co and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nang Kuang Pharmaceutical Co's current Net Margin % is 14.27%, which is 28% above median its own 10-year median of 11.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nang Kuang Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Nang Kuang Pharmaceutical Co (TPE:1752) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$46.62, compared to a current price of NT$31.35 — trading 32.8% below its estimated fair value. The current Net Margin % is 14.27%, which is 28% above median its 10-year median of 11.18 and 597.8% above the Medical Devices & Instruments industry median of 2.05. Nang Kuang Pharmaceutical Co's overall GF Score™ is 88/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Nang Kuang Pharmaceutical Co (TPE:1752), the current Net Margin % is 14.27% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nang Kuang Pharmaceutical Co (TPE:1752) Overvalued in 2026?
Based on GuruFocus' analysis, Nang Kuang Pharmaceutical Co stock appears to be undervalued.
The current stock price of NT$31.35 is trading 32.8% below its estimated GF Value™ of NT$46.62.
GuruFocus considers Nang Kuang Pharmaceutical Co to be Significantly Undervalued.
Key valuation signals for TPE:1752:
Net Margin %: 14.27% (28% above median its 10-year median of 11.18)
GF Value™: NT$46.62 vs. price of NT$31.35 (32.8% below fair value)
Industry Position: 597.8% above the Medical Devices & Instruments median (#193 of 818)
No single metric tells the full story. See the TPE:1752 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nang Kuang Pharmaceutical Co Ltd is a Taiwan-based company, its subsidiaries are engaged in the manufacture, processing, and trading, and import and export of pharmaceuticals and medical devices. Its products are Cardiovascular system medications, Gastrointestinal medications, Nervous system drugs, Nutrition and Metabolism, Hospital infusion solution, blood products, Anticancer immunomodulators, Musculoskeletal system, and Others. Geographically, the company operates in Taiwan, China, Japan, the USA, and Other countries.
88GF Score
Get the complete analysis for TPE:1752
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1752 has been successfully added to your 
